Research programme: chimeric antigen receptor T cell therapeutics - PatrysAlternative Names: CAR immunotherapies - Patrys; CAR T-cell therapeutics - Patrys
Latest Information Update: 30 Oct 2014
At a glance
- Originator Patrys
- Class CAR-T cell therapies; Gene therapies
- Mechanism of Action T-cell receptor antigen modulators; T-cell receptor gene modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Cancer
Most Recent Events
- 15 Mar 2016 Biomarkers information updated
- 24 Jul 2014 Early research in Cancer in Australia (Parenteral)